ALK and diffuse large B-cell lymphoma: This novel ALK-TOPK pathway may also function in other ALK-positive cancers, such as diffuse large B-cell lymphoma or inflammatory breast cancer [23], and TOPK could be a favorable target for the treatment of ALK-positive cancers.